Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nura Bio

Request full access

Clinical-stage SARM1 inhibitors for axon-protective neurotherapeutics

San Francisco, United StatesFounded 2018Biotech & Life Sciences

About Nura Bio

Nura Bio is a South San Francisco clinical-stage biopharmaceutical company developing oral neuroprotective small molecules that inhibit SARM1, a NAD hydrolase that drives axon degeneration across central, peripheral and ocular nervous-system diseases. Led by CEO Shilpa Sambashivan, its pipeline includes NB-4746, a brain-penetrant reversible orthosteric SARM1 inhibitor in a Phase 1b/2a ALS study after a healthy-volunteer Phase 1 that showed favorable safety and target CSF exposure, and NB-9402, a next-generation covalent allosteric SARM1 inhibitor that has entered first-in-human dosing. In June 2026 Nura Bio completed a $73.8 million Series B financing led by The Column Group, with Euclidean Capital, Samsara BioCapital and Sanofi Ventures, to fund clinical proof-of-biology studies for its SARM1 inhibitor portfolio. Sources: Nura Bio / GlobeNewswire 22 Jun 2026.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
San Francisco, United States
Employees
33
Open positions
3
Dealroom signal
50.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Neurology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Jun 2026 $74M $295M Undisclosed ↗
SERIES AOther financing Sep 2024 $68M $272M Sanofi Ventures · Euclidean Capital · Samsara BioCapital · The Column Group ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Nura Bio website traffic

Latest recorded traffic for Nura Bio is 4K monthly website visits, up 66.7% over the last three months. Nura Bio's team grew 10% over the past year.

Latest monthly visits4K 3-month web change+66.7% 1-year team growth+10%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nura Bio in the San Francisco ecosystem

Live from Dealroom

The Nura Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • The Column Group
  • Euclidean Capital
  • Samsara BioCapital
  • Sanofi Ventures

Other known investors2 additional known investors

  • Oregon Health & Science University
  • The University of Texas Southwestern Medical School
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nura Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nura Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.